bazedoxifene has been researched along with Innate Inflammatory Response in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baokun, Z; Erzhu, Y; Jianguang, X; Qiang, S; Xiaofeng, L; Xin, W; Zhiheng, C | 1 |
| Duan, XB; Gao, G; Guo, R; Li, D; Li, X; Ning, W; Zhang, X; Zhou, Y | 1 |
| Guo, R; Huang, P; Lv, Y; Nie, F; Pei, Q; Song, W; Tang, Z | 1 |
3 other study(ies) available for bazedoxifene and Innate Inflammatory Response
| Article | Year |
|---|---|
Biodegradable bilayer hydrogel membranes loaded with bazedoxifene attenuate blood-spinal cord barrier disruption via the NF-κB pathway after acute spinal cord injury.
Topics: Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Hemorrhage; Hydrogels; Inflammation; NF-kappa B; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Tight Junction Proteins | 2023 |
Bazedoxifene attenuates intestinal injury in sepsis by suppressing the NF-κB/NLRP3 signaling pathways.
Topics: Animals; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis; Signal Transduction | 2023 |
Bazedoxifene Plays a Protective Role against Inflammatory Injury of Endothelial Cells by Targeting CD40.
Topics: Anti-Inflammatory Agents; Antioxidants; CD40 Antigens; Cell Adhesion; Cell Movement; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Inflammation; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; THP-1 Cells; Tumor Necrosis Factor-alpha | 2020 |